Dermal fillers: FDA adverse event reports by year
How many adverse event reports has FDA received for dermal fillers?
FDA’s MAUDE database holds 23,207 reports under the dermal filler product codes LMH and PKY (openFDA data updated November 4, 2026), 1,825 of them received in 2025: 19,476 marked Injury, 1,645 marked Malfunction and 15 marked Death by the submitter. Botulinum toxin products are biologic drugs, not devices, so they are not in these counts. A report is not proof the device caused the event. In FDA’s words, “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.”
Counts of FDA MAUDE medical device reports under LMH (dermal implants for aesthetic use) and PKY (for aesthetic use in the hands), by the year FDA received them and the event type the submitter chose. 987 LMH reports have a blank event type. No report text is read or shown, and no report is tied to a clinic.
| LMH | Implant, Dermal, For Aesthetic Use, class 3 | 23,202 | 15 | 19,471 | 1,645 | 2,071 |
| PKY | Implant, Dermal, For Aesthetic Use In The Hands, class 3 | 5 | 0 | 5 | 0 | 0 |
Reports by year received
FDA says “MDR data is not intended to be used either to evaluate rates of adverse events, evaluate a change in event rates over time, or to compare adverse event occurrence rates across devices.”
| 2026 (part year) | 1,750 | 3 | 1,737 | 5 | 5 | 0 |
| 2025 | 1,825 | 1 | 1,819 | 5 | 0 | 0 |
| 2024 | 1,393 | 0 | 1,386 | 7 | 0 | 0 |
| 2023 | 1,478 | 1 | 1,471 | 5 | 1 | 0 |
| 2022 | 1,359 | 0 | 1,350 | 8 | 0 | 1 |
| 2021 | 1,422 | 1 | 1,413 | 8 | 0 | 0 |
| 2020 | 1,156 | 1 | 1,145 | 10 | 0 | 0 |
| 2019 | 1,273 | 2 | 1,154 | 115 | 0 | 2 |
| 2018 | 1,804 | 1 | 1,140 | 663 | 0 | 0 |
| 2017 | 1,510 | 1 | 957 | 552 | 0 | 0 |
| 2016 | 691 | 0 | 687 | 4 | 0 | 0 |
| 2015 | 886 | 1 | 851 | 6 | 20 | 8 |
| 2014 | 786 | 2 | 693 | 4 | 83 | 4 |
| 2013 | 451 | 0 | 341 | 0 | 105 | 5 |
| 2012 | 402 | 0 | 262 | 0 | 126 | 14 |
| 2011 | 449 | 0 | 269 | 2 | 144 | 34 |
| 2010 | 732 | 0 | 485 | 15 | 185 | 47 |
| 2009 | 1,217 | 1 | 269 | 4 | 158 | 785 |
| 2008 | 308 | 0 | 170 | 19 | 107 | 12 |
| 2007 | 175 | 0 | 100 | 19 | 52 | 4 |
| 2006 | 131 | 0 | 86 | 10 | 27 | 8 |
| 2005 | 130 | 0 | 67 | 13 | 20 | 30 |
| 2004 | 163 | 0 | 124 | 14 | 21 | 4 |
| 2003 | 217 | 0 | 174 | 31 | 10 | 2 |
| 2002 | 190 | 0 | 154 | 26 | 5 | 5 |
| 2001 | 154 | 0 | 127 | 14 | 4 | 9 |
| 2000 | 200 | 0 | 158 | 35 | 1 | 6 |
| 1999 | 263 | 0 | 245 | 17 | 1 | 0 |
| 1998 | 291 | 0 | 271 | 18 | 1 | 1 |
| 1997 | 293 | 0 | 276 | 9 | 8 | 0 |
| 1996 | 102 | 0 | 94 | 7 | 0 | 1 |
| 1995 | 1 | 0 | 0 | 0 | 0 | 1 |
| 1994 | 4 | 0 | 1 | 0 | 0 | 3 |
| 1993 | 1 | 0 | 0 | 0 | 0 | 1 |
Brand names on LMH reports
| SCULPTRA | 1,602 |
| JUVEDERM VOLUMA XC/LIDO (VOLUME UNKNOWN) | 1,088 |
| JUVEDERM VOLUMA XC 27G 2 X 1ML | 885 |
| JUVEDERM ULTRA XC TSK US | 682 |
| UNK VOLBELLA | 676 |
| VOLBELLA WITH LIDOCAINE | 640 |
| JUVEDERM VOLUMA WITH LIDOCAINE 1ML | 620 |
| RADIESSE DERMAL FILLER | 596 |
| JUVEDERM (VOLUME/CONCENTRATION/ADDITIVE UNKNOWN) | 506 |
| JUVEDERM ULTRA PLUS XC TSK US | 494 |
| ZYPLAST COLLAGEN IMPLANT | 467 |
| UNK JUVEDERM VOLUX | 462 |
| VOLIFT WITH LIDOCAINE | 456 |
| RADIESSE INJECTABLE IMPLANT | 441 |
| JUVEDERM VOLUMA (VOLUME/ADDITIVE UNKNOWN) | 428 |
| JUVEDERM VOLLURE XC 2X1 ML | 424 |
| VOLIFT (VOLUME UNKNOWN) | 414 |
| JUVEDERM VOLUMA WITH LIDOCAINE 1ML SKU1 | 346 |
| SCULPTRA (POLY-L-LACTIC ACID) | 283 |
| BELOTERO BALANCE | 252 |
Manufacturer names and every code: dermal filler device reports.
FDA’s own description of the limits of these reports, quoted from its MAUDE database page:
- “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.”
- “MDR data is not intended to be used either to evaluate rates of adverse events, evaluate a change in event rates over time, or to compare adverse event occurrence rates across devices.”
Common questions
Are Botox reports included?
No. Botulinum toxin products are regulated as biologic drugs, and their adverse events are reported to FDA’s drug reporting system (FAERS), not MAUDE.
Does a report mean a filler caused the problem described?
No. FDA says “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.”
Why does one brand appear under several names?
Names are shown as submitters wrote them, including volume, needle size or “unknown” prefixes, and are not merged.
Sources
- FDA MAUDE medical device reports, via the openFDA device adverse event API
- FDA, About the MAUDE database
- FDA MAUDE search
Records last pulled Nov 11, 2026. Every entry links to the original public record.
This page counts FDA medical device reports as openFDA publishes them, by product code. A report is a submitter’s account of an event, not proof the device caused it; FDA says “The submission of an MDR itself does not necessarily demonstrate that the device caused or contributed to the adverse outcome or event.” Reports are not tied to any clinic listed here, and report narratives are not republished. Report an error or add a company response.